Young-Soy Rho Selected Research

4- amino- 2- (butyrylamino)phenyl(2E,4E,6E,8E)- 3,7- dimethyl- 9- (2,6,6- trimethyl- 1- cyclohexenyl)- 2,4,6,8- nonatetraenoate

12/2003

Novel retinoic acid derivative ABPN has potent inhibitory activity on cell growth and apoptosis in cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young-Soy Rho Research Topics

Disease

5	Neoplasms (Cancer) 05/2004 - 10/2003
2	Colonic Neoplasms (Colon Cancer) 05/2004 - 12/2003
1	Lung Neoplasms (Lung Cancer) 03/2004
1	Ovarian Neoplasms (Ovarian Cancer) 10/2003

Drug/Important Bio-Agent (IBA)

4	RetinoidsIBA 05/2004 - 10/2003
4	FenretinideIBA 05/2004 - 12/2003
2	retinamideIBA 05/2004 - 10/2003
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2004 - 12/2003
1	DAPIIBA 03/2004
1	Butyric Acid (Butanoic Acid)IBA 03/2004
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 12/2003
1	Vitamin A (Retinol)FDA LinkGeneric 12/2003
1	4- amino- 2- (butyrylamino)phenyl(2E,4E,6E,8E)- 3,7- dimethyl- 9- (2,6,6- trimethyl- 1- cyclohexenyl)- 2,4,6,8- nonatetraenoateIBA 12/2003
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2003
1	Pharmaceutical PreparationsIBA 10/2003

Therapy/Procedure

1	Therapeutics 12/2003
1	Chemoprevention 12/2003